Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
47M
-
Shares change
-
+930K
-
Total reported value, excl. options
-
$2.69B
-
Value change
-
+$50.5M
-
Put/Call ratio
-
1.21
-
Number of buys
-
90
-
Number of sells
-
-77
-
Price
-
$57.17
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2017
210 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2017.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47M shares
of 58.6M outstanding shares and own 80.2% of the company stock.
Largest 10 shareholders include FMR LLC (7.31M shares), WELLINGTON MANAGEMENT GROUP LLP (6.83M shares), Vanguard Group Inc (3.3M shares), Capital International Investors (2.81M shares), BlackRock Inc. (2.81M shares), BB BIOTECH AG (2.72M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.82M shares), Clearbridge Investments, LLC (1.53M shares), STATE STREET CORP (1.34M shares), and Balyasny Asset Management LLC (1.13M shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.